M003
R-(−)-异戊烯基 盐酸盐
≥98% (HPLC), MAO-B inhibitor, powder
别名:
(R)-(−)-N,α-Dimethyl-N-(2-propynyl)phenethylamine hydrochloride, R(−)-N-α-Dimethyl-N-2-propynyl-benzeneethanamine hydrochloride, Selegiline hydrochloride
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C13H17N · HCl
化学文摘社编号:
分子量:
223.74
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
产品名称
R-(−)-异戊烯基 盐酸盐, powder, ≥98% (HPLC)
Quality Segment
assay
≥98% (HPLC)
form
powder
optical activity
[α]25/D −10.8°, c = 6.48 in H2O(lit.)
color
white
mp
141-142 °C
solubility
H2O: >10 mg/mL
originator
Sanofi Aventis
SMILES string
Cl[H].C[C@H](Cc1ccccc1)N(C)CC#C
InChI
1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
InChI key
IYETZZCWLLUHIJ-UTONKHPSSA-N
Gene Information
human ... MAOB(4129)
Biochem/physiol Actions
Selective MAO-B inhibitor; anti-Parkinsonian agent.
Features and Benefits
This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Acute Tox. 4 Oral - STOT SE 3
target_organs
Central nervous system
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| M003-250MG | 04061835557653 |
| M003-1G | 04061835512720 |